BUZZ-Valeant Pharmaceuticals International Inc: Business plan update on Tuesday
** Canadian drug maker's U.S.-listed shares up 3 pct at $84.20
** Valeant said it would hold conference call on Tuesday to give update on its operations and plans to transition from specialty pharmacy, Philidor
** Valeant CEO Michael Pearson has come under increasing pressure as company's stock plunged from $263.70 on Aug. 5 to below $80 last week on scrutiny over high price markups for its drugs and accusations it used Philidor to inflate revenue
** TAKE A LOOK-Valeant cuts ties with beleaguered pharmacy
** Up to Friday's close, stock had fallen 66 pct since Sept. 18, a day before Democratic Presidential candidate Hillary Clinton tweeted about pharmaceutical price gouging
© Thomson Reuters 2017 All rights reserved.